can compound pharmacies sell tirzepatide Compounded FDA says compounding pharmacies can

In the present study, a mouse model of chronic oxidative stress due to compromised de novo GSH synthesis (GCLM KO) 16 exhibited unexpected protection from chronic alcohol consumption-induced hepatotoxicity and steatosis

[5] [16] This multi-receptor activity drives significant reductions in appetite, caloric intake, and body weight effects that, while therapeutically promising, can also influence how the body regulates temperature

Safety Monitoring and Who Should Proceed With Caution Patients with active bipolar disorder, psychosis, or severe depression require careful provider evaluation before starting GLP-1 therapy

The FDA previously resolved the tirzepatide shortage in October 2024 and the semaglutide shortage in February 2025 , removing the legal basis for continued compounding